Yahoo Web Search

The Hill

AI could soon help with ER admissions, study finds

Researchers...could predict when those visits required admission to the hospital. About 18 percent of those visits—or 159,857—resulted in a person being admitted to...

21 minutes ago

CNN.com

I have a family history of Alzheimer’s disease. I wanted to understand my own risk | CNN

2 days ago

Parade via Yahoo

The Cast of 'Grey's Anatomy' Season 1: Where Are They Now?

5 days ago

Digital Journal

...Positive Final Results from the Phase 2a AIR Trial Demonstrating...Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary ...

Vicore plans to progress buloxibutid to Phase 2b development in the first half of this year. Stockholm, May 20, 2024- Vicore Pharma Holding AB (STO: VICO), a clinical-stage biopharmaceutical ...

1 day ago

BuzzFeed via Yahoo

"Bridgerton" Star Claudia Jessie Explained Why She Was Wearing This Winter Accessory During Season 3, And Dearest Reader, It's...

8 hours ago

Stateline via Yahoo

Missed care, fewer patients: Rural families and clinics feel Medicaid cuts

5 days ago

Medical Xpress

AI can help improve ER admission decisions, study finds

9 hours ago

The Business Journals

Opening date is delayed at South Florida Baptist Hospital in Plant City - Tampa Bay Business Journal

1 day ago

Houston Today

Cozens scores 2nd of game in OT as Canada outlasts Czechia at hockey worlds

2 hours ago

Morningstar

Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)

– Two poster presentations of Mallinckrodt's research for adults with HRS with rapid reduction in kidney function1 provide further insight into treatment with TERLIVAZ for appropriate patients – DUBLIN, May 18, 2024 /PRNewswire/ -- Mallinckrodt plc,

3 days ago